1. PROMISe trial: a pilot, randomized, placebo-controlled trial of magnetic resonance guided focused ultrasound for uterine fibroids 
Vanessa L. Jacoby, M.D., M.A.S., Maureen P. Kohi, M.D., Liina Poder, M.D., Alison Jacoby, M.D., Jeanette Lager, M.D., Michael Schembri, Viola Rieke, Ph.D., Deborah Grady, M.D., M.P.H., Eric Vittinghoff, Ph.D., Fergus V. Coakley, M.D. 
Fertility and Sterility 
Volume 105, Issue 3, Pages (March 2016)
DOI: /j.fertnstert
Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions

2. Figure 1 PROMISe study enrollment.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions

3. Figure 2
Symptom change from baseline to 12 weeks after magnetic resonance-guided focused ultrasound for fibroids (MRgFUS) and the placebo treatment.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions